Skip to product information
1 of 1


Human TWEAK Antibody ELISA Kit

Human TWEAK Antibody ELISA Kit


Regular price Send Inquiry
Regular price Sale price Send Inquiry
Sale Sold out
View full details

Product Details

Human TWEAK Antibody ELISA Kit

Factory Name MultiSciences
Product Code 70-EK1256
CatNum EK1256
Product Name Human TWEAK ELISA Kit
Customs Name Customs Name
Type ELISA Kit
Application ELISA
Reactivity Human
SDS SDS - EK1256
Assay Type Sandwich ELISA
Suitable Sample Type serum, plasma, cell culture supernates
Format 96-well strip plate
Storage 4℃ (unopened)standard stored at -20℃, others stored at 4℃ (opened)
Shipping Condition 4℃
Sample Volume 50 μl
Sensitivity 0.87 pg/ml
Standard Curve Range 15.63- 1000 pg/ml
Spike Recovery Range 88% - 117%
Mean Spike Recovery 1.05
CV of Intra plate 3.7% - 6.6%
CV of Inter plate 4.7% - 6.5%
Components 96-well polystyrene microplate coated with a monoclonal antibody against TWEAK
Human TWEAK Standard, lyophilized
TWEAK Detect Antibody
Standard Diluent
Assay Buffer (10×)
Substrate (TMB)
Stop Solution
Washing Buffer (20×)
Plate Covers

This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human TWEAK.The Human TWEAK ELISA is for research use only. Not for diagnostic or therapeutic procedures. The Human IGFBP-1 ELISA is for research use only. Not for diagnostic or therapeutic procedures. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) was discovered in 1997. The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. Leukocytes are the main source of TWEAK including human resting and activated monocytes, dendritic cells and natural killer cells. TWEAK can induce apoptosis via multiple pathways of cell death in a cell type-specific manner. This cytokine is also found to promote proliferation and migration of endothelial cells, and thus acts as a regulator of angiogenesis. Excessive activation of the TWEAK pathway in chronic injury has been described to promote pathological tissue changes including chronic inflammation, fibrosis and angiogenesis.